Wen‐Hu Hsu

4.1k total citations
98 papers, 3.2k citations indexed

About

Wen‐Hu Hsu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Wen‐Hu Hsu has authored 98 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 38 papers in Surgery and 31 papers in Oncology. Recurrent topics in Wen‐Hu Hsu's work include Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (26 papers) and Esophageal Cancer Research and Treatment (20 papers). Wen‐Hu Hsu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (26 papers) and Esophageal Cancer Research and Treatment (20 papers). Wen‐Hu Hsu collaborates with scholars based in Taiwan, United States and Ireland. Wen‐Hu Hsu's co-authors include Yu–Chung Wu, Po‐Kuei Hsu, Jung‐Jyh Hung, Han‐Shui Hsu, Teh‐Ying Chou, Chien‐Sheng Huang, Yu‐Chung Wu, Biing-Shiun Huang, Chih‐Cheng Hsieh and Min-Hsiung Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wen‐Hu Hsu

97 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Hu Hsu Taiwan 34 2.0k 1.1k 772 527 442 98 3.2k
Noriyoshi Sawabata Japan 34 2.6k 1.3× 786 0.7× 1.1k 1.4× 340 0.6× 379 0.9× 180 3.7k
Françoise Le Pimpec‐Barthes France 39 3.0k 1.5× 1.3k 1.2× 1.2k 1.6× 370 0.7× 306 0.7× 246 4.6k
Chang Young Lee South Korea 29 1.7k 0.8× 616 0.6× 843 1.1× 391 0.7× 361 0.8× 124 2.6k
Tommaso Claudio Mineo Italy 40 2.5k 1.3× 1.4k 1.3× 724 0.9× 397 0.8× 220 0.5× 161 4.4k
Kwhanmien Kim South Korea 40 3.3k 1.7× 1.9k 1.8× 912 1.2× 446 0.8× 883 2.0× 187 4.8k
Guowei Che China 30 1.7k 0.9× 1.1k 1.0× 1.3k 1.7× 664 1.3× 214 0.5× 249 3.8k
Ryoichi Nakanishi Japan 26 1.5k 0.8× 800 0.7× 677 0.9× 436 0.8× 151 0.3× 190 2.4k
Akihide Matsumura Japan 32 2.2k 1.1× 1.1k 1.0× 1.3k 1.6× 504 1.0× 279 0.6× 110 3.8k
Jean‐Léon Lagrange France 27 1.4k 0.7× 583 0.5× 602 0.8× 201 0.4× 375 0.8× 75 2.7k
Wentao Fang China 28 1.6k 0.8× 784 0.7× 524 0.7× 670 1.3× 278 0.6× 193 2.8k

Countries citing papers authored by Wen‐Hu Hsu

Since Specialization
Citations

This map shows the geographic impact of Wen‐Hu Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Hu Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Hu Hsu more than expected).

Fields of papers citing papers by Wen‐Hu Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Hu Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Hu Hsu. The network helps show where Wen‐Hu Hsu may publish in the future.

Co-authorship network of co-authors of Wen‐Hu Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Hu Hsu. A scholar is included among the top collaborators of Wen‐Hu Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Hu Hsu. Wen‐Hu Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chien‐Sheng, et al.. (2024). Long-term follow-up of non-myasthenic patients with early-stage thymoma who underwent extended thymectomy or limited resection. European Journal of Surgical Oncology. 50(6). 108349–108349.
2.
Hsu, Po‐Kuei, Yi‐Ying Lee, Chien‐Sheng Huang, et al.. (2023). Modified En Bloc Esophagectomy for Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy. The Annals of Thoracic Surgery. 115(4). 862–869. 1 indexed citations
3.
Tseng, Yen-Han, Heng‐Sheng Chao, Chao‐Hua Chiu, et al.. (2020). Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer. PLoS ONE. 15(10). e0236503–e0236503. 31 indexed citations
4.
Tseng, Yen-Han, Chih‐Cheng Hsieh, Teh‐Ying Chou, et al.. (2017). Long term oncological outcome of thymoma and thymic carcinoma – an analysis of 235 cases from a single institution. PLoS ONE. 12(6). e0179527–e0179527. 18 indexed citations
6.
Hung, Jung‐Jyh, Yi‐Chen Yeh, Wen-Juei Jeng, et al.. (2015). Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. Journal of Thoracic Oncology. 10(9). 1328–1336. 34 indexed citations
7.
Huang, Chien‐Sheng, Chun-Ku Chen, Po‐Kuei Hsu, et al.. (2013). Relative contraindications for percutaneous tracheostomy: from the surgeons’ perspective. Surgery Today. 44(1). 107–114. 10 indexed citations
8.
Hsu, Po‐Kuei, Yi‐Chen Yeh, Chien‐Sheng Huang, et al.. (2013). Surgical Results of Synchronous Multiple Primary Lung Cancers: Similar to the Stage-Matched Solitary Primary Lung Cancers?. The Annals of Thoracic Surgery. 96(6). 1966–1974. 77 indexed citations
9.
Hsu, Po‐Kuei, Chien‐Sheng Huang, Chih‐Cheng Hsieh, et al.. (2013). Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?. Interactive Cardiovascular and Thoracic Surgery. 17(3). 460–466. 20 indexed citations
10.
Hung, Jung‐Jyh, Wen-Juei Jeng, Wen‐Hu Hsu, et al.. (2012). Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. CHEST Journal. 142(1). 141–150. 34 indexed citations
11.
Hung, Jung‐Jyh, et al.. (2012). Clinical significance of E2F1 protein expression in non-small cell lung cancer. Experimental Hematology and Oncology. 1(1). 18–18. 17 indexed citations
12.
Hsieh, Chih‐Cheng, et al.. (2011). Small Cell Carcinoma of the Esophagus: A Report of 16 Cases From a Single Institution and Literature Review. The Annals of Thoracic Surgery. 91(2). 373–378. 33 indexed citations
13.
Hsieh, Chih‐Cheng, et al.. (2010). Accuracy of helical computed tomography in the detection of pulmonary colorectal metastases. Journal of Thoracic and Cardiovascular Surgery. 141(5). 1207–1212. 14 indexed citations
14.
Lin, Tze‐Yi, et al.. (2009). Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas. Modern Pathology. 22(9). 1139–1150. 64 indexed citations
15.
Hsu, Wen‐Hu, Po‐Kuei Hsu, Chih‐Cheng Hsieh, Chien‐Sheng Huang, & Yu‐Chung Wu. (2009). The Metastatic Lymph Node Number and Ratio Are Independent Prognostic Factors in Esophageal Cancer. Journal of Gastrointestinal Surgery. 13(11). 1913–1920. 59 indexed citations
16.
Hung, Jung‐Jyh, et al.. (2008). Esophageal Carcinosarcoma With Basaloid Squamous Cell Carcinoma and Osteosarcoma. The Annals of Thoracic Surgery. 85(3). 1102–1104. 11 indexed citations
17.
Hsu, Po‐Kuei, Han‐Shui Hsu, Chien‐Sheng Huang, et al.. (2006). En Bloc Resection for Lung Cancer with Chest Wall Invasion. Journal of the Chinese Medical Association. 69(4). 157–161. 15 indexed citations
18.
Kuo, Kuang-Tai, et al.. (2003). Sclerosing hemangioma of the lung: an analysis of 44 cases.. PubMed. 66(1). 33–8. 22 indexed citations
19.
Liu, Hung‐Chang, et al.. (2002). Primary thymic carcinoma. The Annals of Thoracic Surgery. 73(4). 1076–1081. 85 indexed citations
20.
Wang, Chien‐Ying, Han‐Shui Hsu, Yu‐Chung Wu, et al.. (2002). Pulmonary resection for metastases from colorectal adenocarcinomas.. PubMed. 65(1). 15–22. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026